Search clinical trials for: B1962

Total 4 results

Tasly Biopharmaceuticals Co., Ltd.

Not yet recruiting

A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors

Neoplasms Malignant

China
Edge Therapeutics Inc

Terminated

Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (NEWTON2)

Subarachnoid Hemorrhage, Aneurysmal

United States, Canada, Australia, Hong Kong, Israel, New Zealand, Singapore, Finland, Czechia, Austria, Germany
Edge Therapeutics Inc

Completed

Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (NEWTON)

Ruptured Cerebral Aneurysm | Ruptured Berry Aneurysm

United States, Canada, Czechia, Finland
Edge Therapeutics Inc

Terminated

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Subarachnoid Hemorrhage, Aneurysmal

United States, Canada

3

Subscribe